StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a sell rating on the biotechnology company’s stock. Other analysts have also recently issued research reports about the company. Capital One Financial cut GlycoMimetics from an overweight rating to an equal weight […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $32.63, but opened at $31.63. Dyne Therapeutics shares last traded at $31.07, with a volume of 1,011,286 shares trading hands. Wall Street Analysts Forecast Growth A number of research firms have commented on […]
GlycoMimetics (NASDAQ:GLYC) Research Coverage Started at StockNews.com wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Brokers Reduce Earnings Estimates for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up to $2.40 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.